Cargando…
Development of a Method for Screening and Genotyping of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes
[Image: see text] The World Health Organization and the World Health Assembly recommended eradicating hepatitis as a public threat by 2030. The accurate genotyping of hepatitis C virus (HCV) is crucial to achieving this goal because it is vital for the selection of anti-HCV therapy required for comp...
Autores principales: | Warkad, Shrikant Dashrath, Nimse, Satish Balasaheb, Song, Keum-Soo, Kim, Taisun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240817/ https://www.ncbi.nlm.nih.gov/pubmed/32455199 http://dx.doi.org/10.1021/acsomega.0c00386 |
Ejemplares similares
-
HCV Detection, Discrimination, and Genotyping Technologies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2018) -
Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018) -
A Novel Method That Allows SNP Discrimination with 160:1 Ratio for Biosensors Based on DNA-DNA Hybridization
por: Nimse, Satish Balasaheb, et al.
Publicado: (2021) -
Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies
por: Warkad, Shrikant Dashrath, et al.
Publicado: (2019) -
ID-Checker Technology
for the Highly Selective Macroscale
Delivery of Anticancer
Agents to the Cancer Cells
por: Song, Keum-soo, et al.
Publicado: (2022)